Necroptosis and parthanatos are involved in remote lung injury after receiving ischemic renal allografts in rats

Kidney International

Volumn 87, Issue 4, 2015, Pages 738-748

  Zhao, Hailin ^a   Ning, Jiaolin ^a,b   Lemaire, Alexandre ^a   Koumpa, Foteini Stefania ^a   Sun, James J ^a   Fung, Anthony ^a   Gu, Jianteng ^b   Yi, Bin ^b   Lu, Kaizhi ^b   Ma, Daqing ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Necroptosis; PARP 1; Parthanatos; Remote lung injury; Renal transplantation

Indexed keywords

3 AMINOBENZAMIDE; CYCLOSPORIN A; NECROSTATIN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; RECEPTOR INTERACTING PROTEIN KINASE 1; RECEPTOR INTERACTING PROTEIN KINASE 3; UNCLASSIFIED DRUG; 3-AMINOBENZAMIDE; BENZAMIDE DERIVATIVE; CONDITIONED MEDIUM; CYCLOSPORIN; IMIDAZOLE DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; INDOLE DERIVATIVE; NECROSTATIN-1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; PARP1 PROTEIN, RAT; PROTEIN SERINE THREONINE KINASE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RECEPTOR-INTERACTING PROTEIN 3, RAT; RIP1 PROTEIN, RAT; TUMOR NECROSIS FACTOR;

ACUTE GRAFT REJECTION; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY ALLOGRAFT; KIDNEY ISCHEMIA; KIDNEY PROXIMAL TUBULE; KIDNEY TRANSPLANTATION; KIDNEY TUBULE CELL; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; MALE; NECROPTOSIS; NONHUMAN; PARTHANATOS; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; RAT; REMOTE LUNG INJURY; REPERFUSION INJURY; ACUTE LUNG INJURY; ADVERSE EFFECTS; ALLOTRANSPLANTATION; ANIMAL; BROWN NORWAY RAT; CELL CULTURE; COMPLICATION; CONDITIONED MEDIUM; CYTOLOGY; DNA FRAGMENTATION; DRUG EFFECTS; GRAFT REJECTION; LEWIS RAT; LUNG; METABOLISM; NECROSIS; PATHOLOGY; PHARMACOLOGY;

ACUTE LUNG INJURY; ANIMALS; BENZAMIDES; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYCLOSPORINE; DNA FRAGMENTATION; GRAFT REJECTION; HUMANS; IMIDAZOLES; IMMUNOSUPPRESSIVE AGENTS; INDOLES; KIDNEY TRANSPLANTATION; KIDNEY TUBULES, PROXIMAL; LUNG; MALE; NECROSIS; POLY(ADP-RIBOSE) POLYMERASE INHIBITORS; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, INBRED BN; RATS, INBRED LEW; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; REPERFUSION INJURY; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84926469754     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.388     Document Type: Article

References (49)

1. Siedlecki A, Irish W, Brennan DC. Delayed graft function in the kidney transplant. Am J Transplant 2011; 11: 2279-2296.
2. Perico N, Cattaneo D, Sayegh MH et al. Delayed graft function in kidney transplantation. Lancet 2004; 364: 1814-1827.
3. Lu CY, Penfield JG, Kielar ML et al. Hypothesis: is renal allograft rejection initiated by the response to injury sustained during the transplant process? Kidney Int 1999; 55: 2157-2168.
4. Mikhalski D, Wissing KM, Ghisdal L et al. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression. Transplantation 2008; 85: S3-S9.
5. Deng J, Hu X, Yuen PS et al. Alpha-melanocyte-stimulating hormone inhibits lung injury after renal ischemia/reperfusion. Am J Respir Crit Care Med 2004; 169: 749-756.
6. Ishii H, Ishibashi M, Takayama M et al. The role of cytokine-induced neutrophil chemoattractant-1 in neutrophil-mediated remote lung injury after intestinal ischaemia/reperfusion in rats. Respirology 2000; 5: 325-331.
7. Colletti LM, Kunkel SL, Walz A et al. Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. The role of epithelial neutrophil activating protein. J Clin Invest 1995; 95: 134-141.
8. Harkin DW, Barros D'Sa AA, McCallion K et al. Ischemic preconditioning before lower limb ischemia-reperfusion protects against acute lung injury. J Vasc Surg 2002; 35: 1264-1273.
9. Grams ME, Rabb H. The distant organ effects of acute kidney injury. Kidney Int 2012; 81: 942-948.
10. Ko GJ, Rabb H, Hassoun HT. Kidney-lung crosstalk in the critically ill patient. Blood Purif 2009; 28: 75-83.
11. Linkermann A, Green DR. Necroptosis. N Engl J Med 2014; 370: 455-465.
12. Vandenabeele P, Galluzzi L, Vanden Berghe T et al. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 2010; 11: 700-714.
13. Christofferson DE, Yuan J. Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol 2010; 22: 263-268.
14. Galluzzi L, Kroemer G. Necroptosis turns TNF lethal. Immunity 2011; 35: 849-851.
15. Linkermann A, Brasen JH, Himmerkus N et al. Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/ reperfusion injury. Kidney Int 2012; 81: 751-761.
16. Northington FJ, Chavez-Valdez R, Graham EM et al. Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. J Cereb Blood Flow Metab 2011; 31: 178-189.
17. Smith CC, Davidson SM, Lim SY et al. Necrostatin: a potentially novel cardioprotective agent? Cardiovasc Drugs Ther 2007; 21: 227-233.
18. Vanden Berghe T, Linkermann A, Jouan-Lanhouet S et al. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol 2014; 15: 135-147.
19. Sosna J, Voigt S, Mathieu S et al. TNF-induced necroptosis and PARP-1-mediated necrosis represent distinct routes to programmed necrotic cell death. Cell Mol Life Sci 2014; 71: 331-348.
20. Asavarut P, Zhao H, Gu J et al. The role of HMGB1 in inflammationmediated organ injury. Acta Anaesthesiol Taiwan 2013; 51: 28-33.
21. Weinlich R, Oberst A, Dillon CP et al. Protective roles for caspase-8 and cFLIP in adult homeostasis. Cell reports 2013; 5: 340-348.
22. Kuiper JW, Groeneveld AB, Slutsky AS et al. Mechanical ventilation and acute renal failure. Crit Care Med 2005; 33: 1408-1415.
23. Koyner JL, Murray PT. Mechanical ventilation and lung-kidney interactions. Clin J Am Soc Nephrol 2008; 3: 562-570.
24. Faubel S. Pulmonary complications after acute kidney injury. Adv Chronic Kidney Dis 2008; 15: 284-296.
25. Kramer AA, Postler G, Salhab KF et al. Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability. Kidney Int 1999; 55: 2362-2367.
26. Hoke TS, Douglas IS, Klein CL et al. Acute renal failure after bilateral nephrectomy is associated with cytokine-mediated pulmonary injury. J Am Soc Nephrol 2007; 18: 155-164.
27. Klein CL, Hoke TS, Fang WF et al. Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomy. Kidney Int 2008; 74: 901-909.
28. Donnahoo KK, Meng X, Ayala A et al. Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemiareperfusion. Am J Physiol 1999; 277: R922-R929.
29. Doi K, Ishizu T, Fujita T et al. Lung injury following acute kidney injury: kidney-lung crosstalk. Clin Exp Nephrol 2011; 15: 464-470.
30. Degterev A, Huang Z, Boyce M et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005; 1: 112-119.
31. Gunther C, Martini E, Wittkopf N et al. Caspase-8 regulates TNF-alphainduced epithelial necroptosis and terminal ileitis. Nature 2011; 477: 335-339.
32. Linkermann A, Hackl MJ, Kunzendorf U et al. Necroptosis in immunity and ischemia-reperfusion injury. Am J Transplant 2013; 13: 2797-2804.
33. Lau A, Wang S, Jiang J et al. RIPK3-mediated necroptosis promotes donor kidney inflammatory injury and reduces allograft survival. Am J Transplant 2013; 13: 2805-2818.
34. Tait SW, Oberst A, Quarato G et al. Widespread mitochondrial depletion via mitophagy does not compromise necroptosis. Cell reports 2013; 5: 878-885.
35. Kaczmarek A, Vandenabeele P, Krysko DV. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 2013; 38: 209-223.
36. Liaudet L, Pacher P, Mabley JG et al. Activation of poly(ADP-ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation. Am J Respir Crit Care Med 2002; 165: 372-377.
37. Schreiber V, Dantzer F, Ame JC et al. Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol 2006; 7: 517-528.
38. Polo SE, Jackson SP. Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Genes Dev 2011; 25: 409-433.
39. Culmsee C, Zhu C, Landshamer S et al. Apoptosis-inducing factor triggered by poly(ADP-ribose) polymerase and Bid mediates neuronal cell death after oxygen-glucose deprivation and focal cerebral ischemia. J Neurosci 2005; 25: 10262-10272.
40. Murakami K, Enkhbaatar P, Shimoda K et al. Inhibition of poly (ADPribose) polymerase attenuates acute lung injury in an ovine model of sepsis. Shock 2004; 21: 126-133.
41. Su CF, Liu DD, Kao SJ et al. Nicotinamide abrogates acute lung injury caused by ischaemia/reperfusion. Eur Respir J 2007; 30: 199-204.
42. Vaschetto R, Kuiper JW, Musters RJ et al. Renal hypoperfusion and impaired endothelium-dependent vasodilation in an animal model of VILI: the role of the peroxynitrite-PARP pathway. Crit Care 2010; 14: R45.
43. Mota RA, Sanchez-Bueno F, Saenz L et al. Inhibition of poly(ADP-ribose) polymerase attenuates the severity of acute pancreatitis and associated lung injury. Lab Invest 2005; 85: 1250-1262.
44. Huang C, Luo Y, Zhao J et al. Shikonin kills glioma cells through necroptosis mediated by RIP-1. PLoS One 2013; 8: e66326.
45. Zhao H, Yoshida A, Xiao W et al. Xenon treatment attenuates early renal allograft injury associated with prolonged hypothermic storage in rats. FASEB J 2013; 27: 4076-4088.
46. Bilolo KK, Ouyang J, Wang X et al. Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat. Transplantation 2003; 75: 1881-1887.
47. Zingarelli B, Cuzzocrea S, Zsengeller Z et al. Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase. Cardiovasc Res 1997; 36: 205-215.
48. Ma D, Lim T, Xu J et al. Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation. J Am Soc Nephrol 2009; 20: 713-720.
49. Koksel O, Yildirim C, Cinel L et al. Inhibition of poly(ADP-ribose) polymerase attenuates lung tissue damage after hind limb ischemiareperfusion in rats. Pharmacol Res 2005; 51: 453-462.